Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Athena Countouriotis


  • Director at Iovance Biotherapeutics Inc. (IOVA), 2020-06-11
  • President & Ceo at Turning Point Therapeutics Inc. (TPTX), 2020-05-26
  • Director at Passage Bio Inc. (PASG), 2020-03-26
  • Director at Trovagene Inc. (TROV), 2019-06-24
  • Svp, Chief Medical Officer at Adverum Biotechnologies Inc. (ADVM), 2018-02-21
  • Svp And Chief Medical Officer at Halozyme Therapeutics Inc (HALO), 2017-02-24
  • Chief Medical Officer at Ambit Biosciences Corp (AMBI), 2014-11-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TPTX $60.00 4,166 Officer, Director 26,872 2020-05-21 Filing
PASG $14.98 10,000 Director 18,900 2020-03-24 Filing
PASG $18.00 8,900 Director 8,900 2020-03-03 Filing
TPTX $45.00 10,000 Officer, Director 22,000 2019-09-10 Filing
TPTX $18.00 12,000 Officer, Director 12,000 2019-04-22 Filing